{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:00:02Z","timestamp":1761919202931},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,20]],"date-time":"2009-02-20T00:00:00Z","timestamp":1235088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00774-009-0042-1","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T10:59:33Z","timestamp":1235041173000},"page":"347-354","source":"Crossref","is-referenced-by-count":20,"title":["High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue"],"prefix":"10.1007","volume":"27","author":[{"given":"N\u00faria","family":"Gua\u00f1abens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Enjuanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloren\u00e7","family":"Caballer\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jes\u00fas Mart\u00ednez de Osaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dacia","family":"Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Monegal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Par\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,20]]},"reference":[{"key":"42_CR1","first-page":"1356","volume":"85","author":"N Gua\u00f1abens","year":"1990","unstructured":"Gua\u00f1abens N, Par\u00e9s A, Mari\u00f1oso L, Branc\u00f3s MA, Piera C, Serrano S et al (1990) Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 85:1356\u20131361","journal-title":"Am J Gastroenterol"},{"key":"42_CR2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","volume":"125","author":"WD Leslie","year":"2003","unstructured":"Leslie WD, Bernstein CN, Leboff MS, The American Gastroenterological Association Clinical Practice Committee (2003) AGA Technical Review on Osteoporosis in Hepatic Disorders. Gastroenterology 125:941\u2013966","journal-title":"Gastroenterology"},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/8756-3282(93)90310-7","volume":"14","author":"SF Hodgson","year":"1993","unstructured":"Hodgson SF, Dickson ER, Eastell R, Eriksen EF, Bryant SC, Riggs BL (1993) Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 14:819\u2013827","journal-title":"Bone"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","volume":"42","author":"N Gua\u00f1abens","year":"2005","unstructured":"Gua\u00f1abens N, Par\u00e9s A, Ros I, Caballer\u00eda L, Pons F, Vidal S et al (2005) Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 42:573\u2013577","journal-title":"J Hepatol"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, L\u00fbthy R et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"42_CR6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","volume":"139","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N et al (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329\u20131337","journal-title":"Endocrinology"},{"key":"42_CR7","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Koshla","year":"2001","unstructured":"Koshla S (2001) Minireview: the OPG\/RANKL\/RANK System. Endocrinology 142:5050\u20135055","journal-title":"Endocrinology"},{"key":"42_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2004.06.004","volume":"15","author":"S Theoleyre","year":"2004","unstructured":"Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D (2004) The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathological bone remodeling. Cytokine Growth Factor Rev 15:49\u201360","journal-title":"Cytokine Growth Factor Rev"},{"key":"42_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"42_CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-8278(02)00435-X","volume":"38","author":"F Szalay","year":"2003","unstructured":"Szalay F, Hegedus D, Lakatos PL, Tornai I, Bajnook E, Dunkel K et al (2003) High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. J Hepatol 38:395\u2013400","journal-title":"J Hepatol"},{"key":"42_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF03347549","volume":"28","author":"A Gaudio","year":"2005","unstructured":"Gaudio A, Lasco A, Morabito N, Atteritano M, Vergara C, Catalano A et al (2005) Hepatic osteodystrophy: does the osteoprotegerin\/receptor activator of nuclear factor-\u03baB ligand system play a role. J Endocrinol Invest 28:677\u2013682","journal-title":"J Endocrinol Invest"},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2005.05.034","volume":"43","author":"AR Moschen","year":"2005","unstructured":"Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, M\u00fchllechner P et al (2005) The RANKL\/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol 43:973\u2013983","journal-title":"J Hepatol"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GSA (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch (Pathol Anat) 379:103\u2013112","journal-title":"Virchows Arch (Pathol Anat)"},{"key":"42_CR14","first-page":"1","volume":"843","author":"WHO Study Group","year":"1994","unstructured":"WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 843:1\u2013129","journal-title":"World Health Organ Tech Rep Ser"},{"key":"42_CR15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","volume":"14","author":"K Yano","year":"1999","unstructured":"Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A et al (1999) Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14:518\u2013527","journal-title":"J Bone Miner Res"},{"key":"42_CR16","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1210\/jc.2002-020396","volume":"87","author":"A Rogers","year":"2002","unstructured":"Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R (2002) Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab 87:4470\u20134475","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR17","first-page":"631","volume":"86","author":"WS Browner","year":"2001","unstructured":"Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631\u2013637","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR18","first-page":"3162","volume":"86","author":"P Szulc","year":"2001","unstructured":"Szulc P, Hofbauer LC, Heufelder AE, Roth S, Delmas PD (2001) Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status. J Clin Endocrinol Metab 86:3162\u20133165","journal-title":"J Clin Endocrinol Metab"},{"key":"42_CR19","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1359\/jbmr.2002.17.11.1961","volume":"17","author":"D Hegedus","year":"2002","unstructured":"Hegedus D, Fernencz V, Lakatos PL, Meszaros S, Lakatos P, Horvath C et al (2002) Decreased bone density, elevated serum osteoprotegerin, and \u03b2-Cross-Laps in Wilson disease. J Bone Miner Res 17:1961\u20131967","journal-title":"J Bone Miner Res"},{"key":"42_CR20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/j.gastro.2004.02.047","volume":"126","author":"JL Gonzalez-Calvin","year":"2004","unstructured":"Gonzalez-Calvin JL, Mundi JL, Casado FJ, Olivares EG (2004) Bone mineral density and serum levels of estradiol and osteoprotegerin in postmenopausal women with viral cirrhosis. Gastroenterology 126:1225\u20131226","journal-title":"Gastroenterology"},{"key":"42_CR21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1478-3231.2005.01073.x","volume":"25","author":"E F\u00e1brega","year":"2005","unstructured":"F\u00e1brega E, Orive A, Garc\u00eda-Su\u00e1rez C, Garc\u00eda-Unzueta M, Amado A, Pons-Romero F (2005) Osteoprotegerin and RANKL in alcoholic liver cirrhosis. Liver Int 25:305\u2013310","journal-title":"Liver Int"},{"key":"42_CR22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1478-3231.2007.01448.x","volume":"27","author":"A Monegal","year":"2007","unstructured":"Monegal A, Gua\u00f1abens N, Navasa M, Alvarez L, Ozalla D, Peris P et al (2007) Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease. J Liver Int 27:492\u2013497","journal-title":"J Liver Int"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/alcalc\/agl004","volume":"41","author":"E Garc\u00eda-Valdecasas-Campelo","year":"2006","unstructured":"Garc\u00eda-Valdecasas-Campelo E, Gonz\u00e1lez-Reimers E, Santolaria-Fern\u00e1ndez F, De la Vega-Prieto MJ, Milena-Abril A, S\u00e1nchez-P\u00e9rez MJ et al (2006) Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol 41:261\u2013266","journal-title":"Alcohol Alcohol"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/art.10834","volume":"48","author":"L Alvarez","year":"2003","unstructured":"Alvarez L, Peris P, Gua\u00f1abens N, Vidal S, Ros I, Pons F et al (2003) Serum osteoprotegerin and its ligand in Paget\u2019s disease of bone. Relationship to disease activity and effect of treatment with bisphosphonates. Arthritis Rheum 48:824\u2013828","journal-title":"Arthritis Rheum"},{"key":"42_CR25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"LC Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M (2004) Clinical implications of the Osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA 292:490\u2013495","journal-title":"JAMA"},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1023\/A:1020511002025","volume":"19","author":"T Nagano","year":"1999","unstructured":"Nagano T, Yamamoto K, Matsumoto S, Okamoto R, Tagashira M, Ibuki N, Matsumura S, Yabushita K, Okano N, Tsuji T (1999) Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 19:422\u2013427","journal-title":"J Clin Immunol"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1746.2002.02672.x","volume":"17","author":"M Neuman","year":"2002","unstructured":"Neuman M, Angulo P, Malkiewicz I, Jorgensen R, Shear N, Dickson ER, Harver J, Katz G, Lindor K (2002) Tumor necrosis factor alpha and transforming growth factor beta reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol 17:196\u2013202","journal-title":"J Gastroenterol Hepatol"},{"key":"42_CR28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"LC Hofbauer","year":"2000","unstructured":"Hofbauer LC, Koshla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2\u201312","journal-title":"J Bone Miner Res"},{"key":"42_CR29","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/art.10680","volume":"46","author":"B Bolon","year":"2002","unstructured":"Bolon B, Shalhoub V, Kostenuik PJ, Campagnuolo G, Morony S, Boyle WJ et al (2002) Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. Arthritis Rheum 46:3121\u20133135","journal-title":"Arthritis Rheum"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/hep.1840070127","volume":"7","author":"AJ Stellon","year":"1987","unstructured":"Stellon AJ, Webb A, Compston J, Williams R (1987) Low bone turnover state in primary biliary cirrhosis. Hepatology 7:137\u2013147","journal-title":"Hepatology"},{"key":"42_CR31","doi-asserted-by":"crossref","unstructured":"Schett G, Kiechl S, Redlich K, Oberhollenzer F, Weger S, Egger G et al (2004) Soluble RANKL and risk of nontraumatic fracture. JAMA 291:1108\u20131113","DOI":"10.1001\/jama.291.9.1108"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0042-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-009-0042-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0042-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:23Z","timestamp":1559110463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-009-0042-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,20]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s00774-009-0042-1","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,20]]}}}